Home R&D

R&D

FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics
Featured

FairJourney Biologics enters antibody discovery agreement with Pandion Therapeutics

Tess Egginton -
0
95% efficiency for Pfizer & BioNTech’s mRNA-based COVID vaccine candidate
Featured

95% efficiency for Pfizer & BioNTech’s mRNA-based COVID vaccine candidate

Dominic Cuthbert -
0
Lead Pharma and Roche to develop oral small molecules for immune mediated diseases
Featured

Lead Pharma and Roche to develop oral small molecules for immune mediated diseases

Dominic Cuthbert -
0
New Timestrip indicators track coronavirus vaccines
Featured

New Timestrip indicators track coronavirus vaccines

Dominic Cuthbert -
0
Moderna’s COVID-19 vaccine candidate 95% efficient in phase 3 study
Featured

Moderna’s COVID-19 vaccine candidate 95% efficient in phase 3 study

Dominic Cuthbert -
0
J&J and UK collaborating on additional study & agreement of COVID vaccine candidate
Featured

J&J and UK collaborating on additional study & agreement of COVID vaccine candidate

Dominic Cuthbert -
0
Phase 3 success for Pfizer & BioNTech’s COVID vaccine candidate
Featured

Phase 3 success for Pfizer & BioNTech’s COVID vaccine candidate

Dominic Cuthbert -
0
CEPI extends Clover partnership to fund COVID vaccine candidate development
Featured

CEPI extends Clover partnership to fund COVID vaccine candidate development

Dominic Cuthbert -
0
RCPE awarded two FDA contracts for next-gen pharma technology
Featured

RCPE awarded two FDA contracts for next-gen pharma technology

Dominic Cuthbert -
0
Optibrium enters cheminformatics collaboration with MSD
Featured

Optibrium enters cheminformatics collaboration with MSD

Tess Egginton -
0
123...178Page 1 of 178

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks